Scientists Say Olive Leaf Compound May Help Treat Malignant Mesothelioma, According to Surviving Mesothelioma

Share Article

Researchers say a compound found in the leaves of olive trees could eventually form the basis of a new treatment for mesothelioma.

Oleuropein Mesothelioma Study

Olive Leaf Compound for Mesothelioma?

Data suggest that our oleuropein-enriched fraction from olive leaf extract could have pharmacological application in malignant mesothelioma...

Mesothelioma researchers in Italy say they have found “antiproliferative properties” in the compound that gives olive oil its bitter taste. The discovery may help slow the spread of the aggressive asbestos cancer. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now.

Carla Marchetti of the Consiglio Nazionale delle Ricerche in Genova and a team of Italian colleagues applied a phenylethanoid called oleuropein to mesothelioma cells in the lab.

According to a report in Evidence-Based Complementary and Alternative Medicine, oleuropein slowed the rapid cell growth and division that make mesothelioma so deadly.

“Data suggest that our oleuropein-enriched fraction from olive leaf extract could have pharmacological application in malignant mesothelioma anticancer therapy,” writes Dr. Marchetti.

“It is always encouraging when a new compound - especially one that is naturally-derived - is found to have an impact on mesothelioma since conventional treatments have limited success,” says Alex Strauss, Surviving Mesothelioma’s Managing Editor.

To read more about the oleuropein study and its potential impact on the future of mesothelioma treatment, see Olive Leaf Compound Could Lead to New Mesothelioma Treatment, available now on the Surviving Mesothelioma website.

Marchetti, C, et al, “Oleuropein-Enriched Olive Leaf Extract Affects Calcium Dynamics and Impairs Viability of Malignant Mesothelioma Cells”, 2015, Evidence-Based Complementary and Alternative Medicine, Epub ahead of print, http://www.hindawi.com/journals/ecam/2015/908493/

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website